Patrick Loustau

Chief Executive Officer at

Granite Bio AG

63 year

Health Technology

Consumer Services

Profile

Patrick Loustau is President, Chief Executive Officer & Director at Granite Bio AG since 2025.
Formerly, Mr. Loustau was Senior Vice President-Global Commercialization at Bristol Myers Squibb Co. in 2014, President at Zafgen, Inc. from 2014 to 2016, and Senior VP-Global Marketing & Medical Affairs at Novo Nordisk A until 2010.
Education includes graduate studies at Université de Paris XI Paris Sud.

Patrick Loustau active positions

Companies	Position	Start
Granite Bio AG Granite Bio AG BiotechnologyHealth Technology Operates as a biotechnology company which develops therapeutic antibodies	Chief Executive Officer	01/02/2025

All active positions of Patrick Loustau

Former positions of Patrick Loustau

Companies	Position	End
LARIMAR THERAPEUTICS, INC.	President	19/07/2016
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	01/04/2014
NOVO NORDISK A/S	Corporate Officer/Principal	01/07/2010

See the detail of Patrick Loustau's experience

Training of Patrick Loustau

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick Loustau's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Zafgen, Inc. Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company	Health Technology
Université de Paris XI Paris Sud Université de Paris XI Paris Sud Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Granite Bio AG Granite Bio AG BiotechnologyHealth Technology Operates as a biotechnology company which develops therapeutic antibodies	Health Technology